| dbo:abstract |
كانتوزوماب رافتانسين هو جسم مضاد وحيد النسيلة مصمم لعلاج السرطان، الجسم المضاد فيه مرتبط بمادة سامة للخلايا هي . (ar) Cantuzumab ravtansine (huC242-SPDB-DM4) is an antibody-drug conjugate designed for the treatment of cancers. The humanized monoclonal antibody cantuzumab (huC242) is linked to a cytotoxic agent, ravtansine (DM4). It uses a more hindered disulfide linkage than cantuzumab mertansine. (en) |
| dbo:casNumber |
868747-45-9 |
| dbo:fdaUniiCode |
RNQ8JQ4R9P |
| dbo:kegg |
D10454 |
| dbo:wikiPageID |
33567643 (xsd:integer) |
| dbo:wikiPageLength |
2885 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1084069775 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Cantuzumab_mertansine dbr:Antibody-drug_conjugate dbc:Immunology dbc:Antibody-drug_conjugates dbr:Monoclonal_antibody dbr:MUC1 dbr:Cytotoxic_agent dbc:Monoclonal_antibodies dbr:Disulfide dbr:ImmunoGen dbr:Ravtansine |
| dbp:atcPrefix |
none (en) |
| dbp:casNumber |
868747 (xsd:integer) |
| dbp:chemspiderid |
none (en) |
| dbp:kegg |
D10454 (en) |
| dbp:mabType |
mab (en) |
| dbp:source |
zu/o (en) |
| dbp:target |
dbr:MUC1 |
| dbp:type |
mab (en) |
| dbp:unii |
RNQ8JQ4R9P (en) |
| dbp:verifiedfields |
changed (en) |
| dbp:verifiedrevid |
459588924 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Keggcite dbt:Monoclonal-antibody-stub dbt:Monoclonals_for_tumors |
| dcterms:subject |
dbc:Immunology dbc:Antibody-drug_conjugates dbc:Monoclonal_antibodies |
| gold:hypernym |
dbr:Conjugate |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodies yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459 |
| rdfs:comment |
كانتوزوماب رافتانسين هو جسم مضاد وحيد النسيلة مصمم لعلاج السرطان، الجسم المضاد فيه مرتبط بمادة سامة للخلايا هي . (ar) Cantuzumab ravtansine (huC242-SPDB-DM4) is an antibody-drug conjugate designed for the treatment of cancers. The humanized monoclonal antibody cantuzumab (huC242) is linked to a cytotoxic agent, ravtansine (DM4). It uses a more hindered disulfide linkage than cantuzumab mertansine. (en) |
| rdfs:label |
كانتوزوماب رافتانسين (ar) Cantuzumab ravtansine (en) |
| owl:sameAs |
freebase:Cantuzumab ravtansine yago-res:Cantuzumab ravtansine wikidata:Cantuzumab ravtansine dbpedia-ar:Cantuzumab ravtansine https://global.dbpedia.org/id/4ev1h |
| prov:wasDerivedFrom |
wikipedia-en:Cantuzumab_ravtansine?oldid=1084069775&ns=0 |
| foaf:isPrimaryTopicOf |
wikipedia-en:Cantuzumab_ravtansine |
| is dbo:wikiPageWikiLink of |
dbr:Cantuzumab_mertansine dbr:Index_of_immunology_articles dbr:Cantuzumab dbr:List_of_therapeutic_monoclonal_antibodies dbr:List_of_drugs:_C–Ca |
| is foaf:primaryTopic of |
wikipedia-en:Cantuzumab_ravtansine |